Arthritis, Psoriatic: all 594 studies

Page 2 of 6. Open to participants first (132), then studies with results posted, then the rest; newest registration first within each.

• SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesRecruitingNCT05598684
• Cytokine Expression in Psoriasis Patients With and Without Joint InvolvementRecruitingNCT05307809Not applicable
• Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic ArthritisRecruitingNCT05291819Not applicable
• The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory ArthritisEnrolling by invitationNCT05257174Not applicable
• Biobank for Inflammatory Chronic Diseases and OsteoporosisRecruitingNCT05039216
• Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory DiseasesRecruitingNCT04924270Phase 2
• Personal Precise Treatment on Psoriasis and Psoriatic ArthritisNot yet recruitingNCT04915105Not applicable
• Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved IndicationsRecruitingNCT04846959
• Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
• Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/DermatologistRecruitingNCT04800289
• Arthroscopic Synovectomy of the Wrist in Inflammatory ArthritisRecruitingNCT04755127Not applicable
• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruitingNCT04751396
• Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.RecruitingNCT04731831
• Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
• Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
• Deployment o the Multidisciplinary Prospective Cohort ImminentRecruitingNCT04334031Not applicable
• Evolution and Treatments of Chronic Inflammatory Systemic DiseasesRecruitingNCT04191395
• GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, SwedenEnrolling by invitationNCT04190758
• Expanded Access to UpadacitinibAvailableNCT04159597
• Safety and Efficacy of Fecal Microbiota TransplantationRecruitingNCT04014413Not applicable
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
• APACHE Cohort (A Psoriatic Arthritis CoHort)RecruitingNCT03768271
• Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles TendonsRecruitingNCT03248284
• Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesRecruitingNCT03214263
• Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic ArthritisRecruitingNCT02572700
• The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) RegistryEnrolling by invitationNCT02530268
• Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruitingNCT02418442
• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruitingNCT02103361
• Korean College of Rheumatology Biologics and Targeted Therapy RegistryRecruitingNCT01965132
• PsoBest - the German Psoriasis RegistryRecruitingNCT01848028
• CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness RegistryEnrolling by invitationNCT01402661
• German Spondyloarthritis Inception CohortRecruitingNCT01277419
• A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in IndiaCompletedNCT05855967Phase 4Results posted
• A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)CompletedNCT05758402Not applicableResults posted
• Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisCompletedNCT05640245Phase 2Results posted
• Psoriatic Arthritis Study of IzokibepTerminatedNCT05623345Phase 2/3Results posted
• A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic ArthritisCompletedNCT05195814Results posted
• AsseSSing Impact in pSoriatic TreatmentCompletedNCT05171270Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic ArthritisCompletedNCT05153148Phase 2Results posted
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisCompletedNCT05071664Phase 2Results posted
• Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha AgentCompletedNCT04936308Phase 3Results posted
• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic DrugsActive, not recruitingNCT04908202Phase 3Results posted
• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor TreatmentActive, not recruitingNCT04908189Phase 3Results posted
• A Study of Guselkumab in Participants With Active Psoriatic ArthritisActive, not recruitingNCT04882098Phase 3Results posted
• Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.CompletedNCT04711902Phase 3Results posted
• Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor TreatmentCompletedNCT04632927Phase 3Results posted
• Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical PracticeCompletedNCT04517669Results posted
• Regulation of Mucosal Healing in Inflammatory Bowel DiseaseCompletedNCT04504136Not applicableResults posted
• Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)CompletedNCT04428502Results posted
• Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic ArthritisTerminatedNCT04269993Phase 2Results posted
• Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic ArthritisCompletedNCT04209205Phase 3Results posted
• Diet Interventions in Psoriatic ArthritisCompletedNCT04180904Not applicableResults posted
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)CompletedNCT04163016Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD TherapyTerminatedNCT04115839Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD TherapyTerminatedNCT04115748Phase 3Results posted
• A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic ArthritisCompletedNCT04109976Phase 3Results posted
• GOLimumab and Methotrexate Versus Methotrexate in Very Early PsACompletedNCT04108468Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic ArthritisCompletedNCT03963401Phase 2Results posted
• Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisCompletedNCT03926195Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompletedNCT03896581Phase 3Results posted
• A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompletedNCT03895203Phase 3Results posted
• Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)CompletedNCT03885089Results posted
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)CompletedNCT03881059Phase 2Results posted
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyCompletedNCT03835780Results posted
• Psoriatic Oligoarthritis Intervention With Symptomatic thErapyCompletedNCT03797872Phase 4Results posted
• A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic ArthritisCompletedNCT03783026Phase 4Results posted
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.CompletedNCT03747939Phase 4Results posted
• Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED TrialCompletedNCT03739853Phase 4Results posted
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT03733925Phase 4Results posted
• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) TherapyActive, not recruitingNCT03675308Phase 3Results posted
• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)CompletedNCT03671148Phase 3Results posted
• Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.CompletedNCT03552276Phase 2/3Results posted
• Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic ArthritisCompletedNCT03531073Results posted
• Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic ArthritisCompletedNCT03486457Phase 3Results posted
• A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03410992Phase 3Results posted
• Psoriatic Arthritis Research Collaborative: Biologic Sub-StudyCompletedNCT03378336Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03370133Phase 3Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted
• A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic ArthritisCompletedNCT03347110Phase 2Results posted
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)CompletedNCT03162796Phase 3Results posted
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic ArthritisCompletedNCT03158285Phase 3Results posted
• A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic ArthritisCompletedNCT03151551Phase 4Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)CompletedNCT03104400Phase 3Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugCompletedNCT03104374Phase 3Results posted
• Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)CompletedNCT03031782Phase 3Results posted
• Low Dose Naltrexone for Chronic Pain From ArthritisCompletedNCT03008590Phase 2Results posted
• A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)CompletedNCT02986373Phase 2Results posted
• Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic ArthritisCompletedNCT02986139Phase 3Results posted
• Korean Post-marketing Surveillance for XeljanzCompletedNCT02984020Results posted
• Efficacy and Safety Study of SUNPG1623CompletedNCT02980692Phase 2Results posted
• A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory ArthritisCompletedNCT02969525Phase 2Results posted
• National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeCompletedNCT02925338Results posted
• A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)CompletedNCT02814175Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to PlaceboCompletedNCT02798211Phase 4Results posted
• Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon SiteCompletedNCT02771210Phase 3Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic ArthritisCompletedNCT02745080Phase 3Results posted
• Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton InvolvementCompletedNCT02721966Phase 3Results posted
• BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic ArthritisCompletedNCT02719171Phase 2Results posted
• Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT02662985Phase 3Results posted

← Arthritis, Psoriatic overview